Short peptides break down Alzheimer’s tau fibrils
In a groundbreaking advance that could reshape therapeutic approaches for Alzheimer’s disease (AD), researchers have unveiled a detailed mechanism by ...
In a groundbreaking advance that could reshape therapeutic approaches for Alzheimer’s disease (AD), researchers have unveiled a detailed mechanism by ...
In 2023, the Food and Drug Administration (FDA) rendered a groundbreaking decision by approving lecanemab, a novel therapeutic agent aimed ...
In a groundbreaking study conducted by Northwestern Medicine, a new approach to treating Alzheimer’s disease has emerged that focuses on ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine